Coherus BioSciences, Inc. (“Coherus,” NASDAQ: CHRS) today announced that senior management will participate in the 2024 Citi Global Healthcare Conference, with Dr. Theresa LaVallee, Chief Development Officer, sitting on the Novel Mechanisms in Oncology Panel on December 3, 2024, at 3:15 p.m. ET.

The panel discussion will be accessible via webcast through a link on the Investor Events and Presentations section of the Coherus website: https://investors.coherus.com/events-presentations.

Coherus Contact Information:For Investors:Jodi SieversVP, Investor Relations & Corporate CommunicationsIR@coherus.com

Coherus BioSciences (NASDAQ:CHRS)
過去 株価チャート
から 11 2024 まで 12 2024 Coherus BioSciencesのチャートをもっと見るにはこちらをクリック
Coherus BioSciences (NASDAQ:CHRS)
過去 株価チャート
から 12 2023 まで 12 2024 Coherus BioSciencesのチャートをもっと見るにはこちらをクリック